leisure time -WSS

leisure time

author：comprehensive 2025-08-23 05:00:27 - browse：65641

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Childhood cancer progress stalls for Black, Hispanic kids: Report

WSS

Gain of function research would be limited under House proposal

Congress must reauthorize a committee to support older Americans

Neuroscience’s long legacy of racism

Weight loss drug costs may need more research, senator suggests

Asbestos, a deadly carcinogen, banned by EPA

Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

World's first CRISPR

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Gain of function research would be limited under House proposal

Novavax promises a turnaround & Lilly roils the obesity market

Gene editing the human germline: What are the risks?

Hollywood unions extend contract negotiations for actors

FDA's Woodcock to retire early next year

hotspot

CRISPR pioneers react to Casgevy, first gene

Congress must reauthorize a committee to support older Americans

FDA's Woodcock to retire early next year

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Does good food count as health care? Study aims to find out

hotspot

focus

hotspot

hotspot